Sinisa Savic
About
In The Last Decade
Sinisa Savic
127 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 1.3k
- Immunology 1.3k
- Rheumatology 649
- Hematology 421
- Infectious Diseases 380
Countries citing papers authored by Sinisa Savic
This map shows the geographic impact of Sinisa Savic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinisa Savic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinisa Savic more than expected).
Fields of papers citing papers by Sinisa Savic
This network shows the impact of papers produced by Sinisa Savic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinisa Savic. The network helps show where Sinisa Savic may publish in the future.
Co-authorship network of co-authors of Sinisa Savic
This figure shows the co-authorship network connecting the top 25 collaborators of Sinisa Savic. A scholar is included among the top collaborators of Sinisa Savic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sinisa Savic. Sinisa Savic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 10 | |
| 10 | 4 | |
| 11 | T cell response in immunosuppressed redo-liver transplant recipients after COVID-19 infection and after first dose of vaccine against SARS-CoV-2 | 1 |
| 12 | Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder | 12 |
| 13 | 29 | |
| 14 | 39 | |
| 15 | 19 | |
| 16 | 86 | |
| 17 | 288 | |
| 18 | 39 | |
| 19 | Zytologie der ableitenden Harnwege: Zwischen Zweifel und Gewissheit | 2 |
| 20 | Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): Focus on rilonacept (IL-1 Trap) | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.